Sign In

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

Past Press Releases - Galantos Pharma

September 9, 2013
Neurodyn Inc. acquires Memogain for Dementia in Alzheimer’s Disease
Neurodyn Inc. and Galantos Pharma GmbH announced today that Neurodyn has acquired from Galantos Pharma GmbH, Mainz, Germany ( all assets related to their Alzheimer’s prescription drug candidate – Memogain®. More

July 6, 2009
Galantos Pharma receives government grant for the development of novel drugs against Alzheimer
Public funding by BMBF speeds up Company’s ambitious preclinical program. More

May 28, 2008
Galantos Pharma receives research grant
Galantos Pharma GmbH, a biopharmaceutical company developing natural product derivatives to treat Alzheimer’s disease (AD) today announced that it has been granted EUR 366.000 from Investitions- und Strukturbank Rheinland-Pfalz (ISB) GmbH, More


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Dec 21€50.0MKnowledge management
Dec 20€16.0MSemiconductors
Dec 17€18.0MOther Computers & Electronics
Dec 17€5.2MBiotechnology
Dec 17€17.0MBusiness applications
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology

For information on Europe's most extensive database on technology funding click here!


Press Releases

Mar 11
the world's most advanced bluetooth key for digital tachographs

Sep 30
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Mar 31
the fit allocates chf 100'000 to comppair technologies

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.